Dr. Natalie E. Cusano, MD

Dr. Cusano practices at Northwell Health Physician Partners Cardiology in New York, New York.

Dr. Cusano's NPI, 1568620425, was assigned on May 28, 2008. Dr. Cusano graduated from Boston University School Of Medicine in 2006. Dr. Cusano holds New York license 253667.

Dr. Cusano's primary practice is Northwell Health Physician Partners Cardiology, at 110 E 59th St, New York, NY 10022 in New York County. The practice phone is (516) 321-7400.

Dr. Cusano's primary practice is Northwell Health Physician Partners Cardiology in New York, New York. Dr. Cusano is also affiliated with Tisch Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Cusano to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cusano practices, 3 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Cusano's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Cusano is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dr. Cusano is licensed in New York.

Dmand AI lists chronic diabetes, diabetic emergency, enlarged thyroid, obesity, osteoporosis, overactive thyroid, parathyroid gland disorder and underactive thyroid among the conditions Dr. Cusano treats.

CMS data shows 19,403 Medicare services from Dr. Cusano across 11 procedure codes in 2024, for 553 Medicare patients. Medicare paid $453,179 for them. Every service was in an office.

CMS counts 553 Medicare patients who saw Dr. Cusano in 2024. The largest group is 65 to 74, with 254 patients. 75% of them have high cholesterol, and 75% have osteoporosis. 11% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cusano's median patient age at 72, with 89% women.

In 2024, Dr. Cusano wrote 2,133 Medicare Part D claims for 380 patients. 43% of them were for generic drugs. CMS names the drug for 1,883 of them, across 31 drugs with 11 or more claims each, at $2,444,254 in total drug cost. In 2023, CMS named 1,851 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Cusano for performance year 2024, reported through an alternative payment model (APM). Dr. Cusano accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cusano as offering telehealth.

Dmand AI links 70 papers to Dr. Cusano, published from 2010 to 2024. 2013 was the busiest year, with 8. The most frequent topics are Parathyroid Hormone, Hypoparathyroidism and Bone Density. Dr. Cusano has published most often in J Clin Endocrinol Metab. Dr. Cusano's most frequent co-authors are John Paul Bilezikian, MD, Mishaela Ruth Rubin, MD and Beatriz Omeragic, MD.

Dmand AI links Dr. Cusano to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Hypoparathyroidism and Parathyroid Diseases.

CMS Open Payments shows 199 general payments to Dr. Cusano from 8 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 72% of the total. Shire North American Group Inc paid the most, $61,340.

Dmand AI lists 1 award for Dr. Cusano, most recently Castle Connolly Top Doctor in 2023.

Dr. Cusano graduated from Boston University School Of Medicine in 2006.

Dr. Cusano is in network with 21 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.